Enzo Wins Interference Ruling In Siemens Patent Spat

Law360, New York (March 1, 2010, 5:56 PM EST) -- The U.S. Patent and Trademark Office's Board of Patent Appeals and Interferences has sided with Enzo Biochem Inc. in an interference dispute with Siemens AG, giving the life sciences company the right to a full term for a patent related to nucleic acid signal amplification used in disease diagnosis.

The appeals board entered judgment for New York-based Enzo and against Siemens — which acquired the patent-at-issue along with Bayer HealthCare LLC's diagnostics division in 2006 — in the dispute over a universal diagnostic detection system, Enzo...
To view the full article, register now.